Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells

References

• Chan AT. Nasopharyngeal carcinoma. Ann Oncol: Off J Euro Soc Med Oncol. 2010;21(Suppl 7):vii308–312. doi:10.1093/annonc/mdq277 PMID:20943634
   PubMedGoogle Scholar
• Xiao WW, Han F, Lu TX, et al. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2009;74:1070–1076. doi:10.1016/j.ijrobp.2008.09.008. PMID:19231110
   PubMed Web of Science ®Google Scholar
• Liang Z, Zhu X, Li L, et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study. Curr Oncol. 2014;21:e408–e417. doi:10.3747/co.21.1777. PMID:24940100
   PubMed Web of Science ®Google Scholar
• Suarez C, Rodrigo JP, Rinaldo A, et al. Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol. 2010;267:1811–1824. doi:10.1007/s00405-010-1385-x. PMID:20865269
   PubMed Web of Science ®Google Scholar
• Yu H, Wang X, Song A, et al. Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2012;13:3961–3965. doi:10.7314/APJCP.2012.13.8.3961. PMID:23098500
   PubMedGoogle Scholar
• Chen YJ. Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin. 2002;23:1102–1106. PMID:12466047
   PubMed Web of Science ®Google Scholar
• Xie QM, Tang HF, Chen JQ, et al. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin. 2002;23:1107–1113. PMID:12466048
   PubMed Web of Science ®Google Scholar
• Chang KH, Chen ML, Chen HC, et al. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma. 1999;46:196–200. PMID:10613597
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen JC, Tseng SH. Effects of tetrandrine plus radiation on neuroblastoma cells. Anticancer Res. 2009;29:3163–3171. PMID:19661330
   PubMed Web of Science ®Google Scholar
• Yu J, Liu F, Sun M, et al. Enhancement of radiosensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine. Cancer Biother Radiopharm. 2011;26:437–442. doi:10.1089/cbr.2011.0964. PMID:21797675
   PubMed Web of Science ®Google Scholar
• Sun X, Xu R, Deng Y, et al. Effects of tetrandrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. Acta Biochimica et Biophysica Sinica. 2007;39:869–878. doi:10.1111/j.1745-7270.2007.00349.x. PMID:17989878
   PubMed Web of Science ®Google Scholar
• Rottey S, Madani I, Deron P, et al. Modern treatment for nasopharyngeal carcinoma: current status and prospects. Curr Opin Oncol. 2011;23:254–258. doi:10.1097/CCO.0b013e328344f527. PMID:21330921
   PubMed Web of Science ®Google Scholar
• Chow JP, Man WY, Mao M, et al. PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy. Mol Cancer Ther. 2013;12:2517–2528. doi:10.1158/1535-7163.MCT-13-0010. PMID:23979918
   PubMed Web of Science ®Google Scholar
• Chua MLK, Wee JTS, Hui EP, et al. Nasopharyngeal carcinoma. Lancet. 2016;387:1012–1024. doi:10.1016/S0140-6736(15)00055-0. PMID:26321262
   PubMed Web of Science ®Google Scholar
• Cavallo F, Feldman DR, Barchi M. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors. Int J Dev Biol. 2013;57:273–280. doi:10.1387/ijdb.130135mb. PMID:23784838
   PubMed Web of Science ®Google Scholar
• Beishline K, Azizkhan-Clifford J. Interplay between the cell cycle and double-strand break response in mammalian cells. Methods Mol Biol. 2014;1170:41–59. doi:10.1007/978-1-4939-0888-2_3. PMID:24906308
   PubMedGoogle Scholar
• Deckbar D, Jeggo PA, Lobrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol. 2011;46:271–283. doi:10.3109/10409238.2011.575764. PMID:21524151
   PubMed Web of Science ®Google Scholar
• Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer. 2008;98:523–528. doi:10.1038/sj.bjc.6604208. PMID:18231106
   PubMed Web of Science ®Google Scholar
• Gogineni VR, Nalla AK, Gupta R, et al. Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett. 2011;313:64–75. doi:10.1016/j.canlet.2011.08.022. PMID:21945852
   PubMed Web of Science ®Google Scholar
• Yong KJ, Milenic DE, Baidoo KE, et al. Sensitization of tumor to (2)(1)(2)Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51. Int J Radiat Oncol Biol Phys. 2013;85:1119–1126. doi:10.1016/j.ijrobp.2012.09.015. PMID:23200172
   PubMed Web of Science ®Google Scholar
• Anastasov N, Hofig I, Vasconcellos IG, et al. Radiation resistance due to high expression of miR-21 and G2M checkpoint arrest in breast cancer cells. Radiat Oncol. 2012;7:206. doi:10.1186/1748-717X-7-206. PMID:23216894
   PubMed Web of Science ®Google Scholar
• Sun XC, Cheng HY, Deng YX, et al. Tetrandrine: a potent abrogator of G2 checkpoint function in tumor cells and its mechanism. Biomed Environ Sci. 2007;20:495–501. PMID:18348409
   PubMed Web of Science ®Google Scholar
• Smits VA, Klompmaker R, Vallenius T, et al. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem. 2000;275:30638–30643. doi:10.1074/jbc.M005437200. PMID:10913154
   PubMed Web of Science ®Google Scholar
• Fisher D, Krasinska L, Coudreuse D, et al. Phosphorylation network dynamics in the control of cell cycle transitions. J Cell Sci. 2012;125:4703–4711. doi:10.1242/jcs.106351. PMID:23223895
   PubMed Web of Science ®Google Scholar
• Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001;2:21–32. doi:10.1038/35048096. PMID:11413462
   PubMed Web of Science ®Google Scholar
• Hou Y, Guo T, Wu C, et al. Effect of tetrandrine combined with epirubicin on the growth of human breast carcinoma multidrug resistance cell line. Yakugaku Zasshi. 2008;128:663–666. doi:10.1248/yakushi.128.663. PMID:18379185
   PubMed Web of Science ®Google Scholar
• Yu VW, Ho WS. Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase. Oncol Rep. 2013;29:2205–2210. doi:10.3892/or.2013.2352. PMID:23525490
   PubMed Web of Science ®Google Scholar
• Qin L, Fan M, Candas D, et al. CDK1 enhances mitochondrial bioenergetics for radiation-induced DNA repair. Cell Rep. 2015;13:2056–2063. doi:10.1016/j.celrep.2015.11.015. PMID:26670043
   PubMed Web of Science ®Google Scholar